Yoshinori Shinohara

Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation

H. Tagawa, N. Takahashi, M. Miura, 2016, Cancer Chemotherapy and Pharmacology.

Massive Ascites Caused by Primary Diffuse Large B-cell Lymphoma of the Jejunum: A Case of a Rare Initial Symptom

K. Higuchi, Taro Iwatsubo, T. Takeuchi, 2020, Internal medicine.

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells

K. Iwaisako, J. Karbach, Hiromasa Morikawa, 2019, The Journal of experimental medicine.

A multicenter clinical study evaluating the confirmed complete molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction

M. Hino, N. Takahashi, K. Itoh, 2013, Haematologica.

Title A multicenter clinical study evaluating the confirmed complete molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction

M. Hino, N. Takahashi, K. Itoh, 2018 .

molecular response rate in imatinib-treated patients with chronic phase chronic myeloid leukemia by using the international scale of real-time quantitative polymerase chain reaction

M. Hino, N. Takahashi, K. Itoh, 2013 .

Dasatinib-responsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia.

N. Takahashi, K. Sawada, M. Kume, 2013, Internal medicine.

Acquired Philadelphia chromosome with transformed myelodysplastic syndrome

N. Takahashi, K. Sawada, M. Kume, 2013 .